Peptide therapy encourages the body to produce its own hormones rather than flooding it with external replacements
Esmaeili N, Gell L, Taranto-Montemurro L, et al
its a safeguard that ensures any interactions are managed properly, enhancing the safety of your treatment
These AIs are higher than the U.S
MT-1 peptide , also known as the melanotan 1 peptide, is a synthetic analog of the natural hormone -melanocyte-stimulating hormone (-MSH)
It is a recombinant form of the peptide exendin-4, which is a GLP-1 receptor agonist with a 53% similarity to the gastrointestinal hormone GLP-1 and it is resistant to DPP-4 inactivation with a 140-minute half-life after subcutaneous administration allowing therapy by a twice daily administration [36]